These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 20858687)

  • 21. Patterns of antimicrobial therapy in severe nosocomial infections: empiric choices, proportion of appropriate therapy, and adaptation rates--a multicentre, observational survey in critically ill patients.
    Vogelaers D; De Bels D; ForĂȘt F; Cran S; Gilbert E; Schoonheydt K; Blot S;
    Int J Antimicrob Agents; 2010 Apr; 35(4):375-81. PubMed ID: 20122817
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ertapenem.
    Parakh A; Krishnamurthy S; Bhattacharya M
    Kathmandu Univ Med J (KUMJ); 2009; 7(28):454-60. PubMed ID: 20502094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Teicoplanin in the therapy of gram-positive infections: an open non-randomized study.
    De Lalla F; Rinaldi E; Santoro D; Rizzardini G; Martello P; Guaglianone MH
    J Chemother; 1989 Jul; 1(4 Suppl):719-21. PubMed ID: 16312606
    [No Abstract]   [Full Text] [Related]  

  • 24. Synthesis and antibacterial activity of quinolone-based compounds containing a coumarin moiety.
    Emami S; Foroumadi A; Faramarzi MA; Samadi N
    Arch Pharm (Weinheim); 2008 Jan; 341(1):42-8. PubMed ID: 18072241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cefixime once-a-day in the treatment of lower respiratory tract infections in adults.
    Capelli O; Bonucchi ME; Ragno T; Azzolini L; Prandi E; Lega M; Toraldo MD; Velluti G
    J Chemother; 1989 Jul; 1(4 Suppl):775-8. PubMed ID: 16312634
    [No Abstract]   [Full Text] [Related]  

  • 26. Conformationally constrained analogs of N-substituted piperazinylquinolones: synthesis and antibacterial activity of N-(2,3-dihydro-4-hydroxyimino-4H-1-benzopyran-3-yl)-piperazinylquinolones.
    Emami S; Foroumadi A; Samadi N; Faramarzi MA; Rajabalian S
    Arch Pharm (Weinheim); 2009 Jul; 342(7):405-11. PubMed ID: 19544301
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Quinolone antibacterials--oral preparation].
    Niki Y
    Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():348-51. PubMed ID: 17455644
    [No Abstract]   [Full Text] [Related]  

  • 28. Tigecycline: a novel glycylcycline antibiotic.
    Zhanel GG; Karlowsky JA; Rubinstein E; Hoban DJ
    Expert Rev Anti Infect Ther; 2006 Feb; 4(1):9-25. PubMed ID: 16441206
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The usefulness of sputum gram stain and culture.
    Musher DM
    Arch Intern Med; 2005 Feb; 165(4):470-1. PubMed ID: 15738381
    [No Abstract]   [Full Text] [Related]  

  • 30. Oral ciprofloxacin, ofloxacin, and lomefloxacin as alternatives to intravenous antimicrobial therapy.
    Belliveau P; Nightingale CH; Quintiliani R; Crowe H; Gousee G
    Conn Med; 1993 Aug; 57(8):539-45. PubMed ID: 8243083
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Microbiological study of nosocomial lung infections].
    Araque-Granadillo MC; Nieves-Blanco BM
    Rev Latinoam Microbiol; 1993; 35(2):147-52. PubMed ID: 8209107
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antimicrobial activity of DW286 against Streptococcus pneumoniae.
    Park HS; Jung SJ; Choi DR; Kwak JH
    Int J Antimicrob Agents; 2010 Sep; 36(3):230-3. PubMed ID: 20627463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Tobramycin in pediatrics. Report of 24 cases].
    Fournet JP; Huault G; Castaing H; Mariel C
    Ann Pediatr (Paris); 1976 Apr; 23(4):293-9. PubMed ID: 16104222
    [No Abstract]   [Full Text] [Related]  

  • 34. Causative agents and antimicrobial susceptibilities of urinary tract infections in the northwest of Iran.
    Farajnia S; Alikhani MY; Ghotaslou R; Naghili B; Nakhlband A
    Int J Infect Dis; 2009 Mar; 13(2):140-4. PubMed ID: 18703368
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overview of the efficacy of isepamicin in the adult core clinical trial programme.
    Carbon C
    J Chemother; 1995 Jun; 7 Suppl 2():79-85. PubMed ID: 8622115
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systemic quinolone antibiotics in children: a review of the use and safety.
    Grady RW
    Expert Opin Drug Saf; 2005 Jul; 4(4):623-30. PubMed ID: 16011441
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and antibacterial activity of N-(5-benzylthio-1,3,4-thiadiazol-2-yl) and N-(5-benzylsulfonyl-1,3,4-thiadiazol-2-yl)piperazinyl quinolone derivatives.
    Foroumadi A; Emami S; Hassanzadeh A; Rajaee M; Sokhanvar K; Moshafi MH; Shafiee A
    Bioorg Med Chem Lett; 2005 Oct; 15(20):4488-92. PubMed ID: 16105736
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A closer look at aerosolized colistin.
    van Leeuwen DH
    Clin Infect Dis; 2011 Jun; 52(12):1472-3; author reply 1473-4. PubMed ID: 21628491
    [No Abstract]   [Full Text] [Related]  

  • 39. Nemonoxacin: first global approval.
    Poole RM
    Drugs; 2014 Aug; 74(12):1445-53. PubMed ID: 25079302
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pazufloxacin.
    Vora A
    J Assoc Physicians India; 2009 Oct; 57():722-3. PubMed ID: 20329436
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.